Search Articles — Sudonull

Search Results

From other projects

FDA agreed on trial design for Privosegtor in optic neuritis

https://ymaho.com/fda-agreed-on-trial-design-for-privosegtor-in-optic-neuritis

FDA approved the design of registration trials for the neuroprotector Privosegtor for the treatment of optic neuritis. Learn how the drug can change neuro-ophthalmology and what prospects the SPA agreement opens.

FDA may approve ophthalmic bevacizumab Lytenava

https://ymaho.com/fda-may-approve-ophthalmic-bevacizumab-lytenava

Analysis of the regulatory paradox: why the FDA rejected it three times, while Europe approved it. Learn how the Lytenava decision will change the $16 billion AMD market.

Targeted therapy for Usher syndrome 1B: new data on AAVB-081

https://ymaho.com/targeted-therapy-for-usher-syndrome-1b-new-data-on-aavb-081

Interim data from phase 1/2 gene therapy AAVB-081 for Usher syndrome 1B: safety, efficacy, and prognosis. Learn about the dual AAV vector and treatment prospects.

Trending Now